Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.

The management and treatment of prostate cancer is evolving to address unmet patient needs, with advancements spanning from diagnosis ...

Findings in patients with interstitial cystitis/bladder pain syndrome can help with diagnosis of interstitial cystitis subtypes ...

A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at https://ir.procept-biorobotics.com/. The webcast will be ...

The Urology Care Foundation is Encouraging You to Be Proactive for National Kidney Month March is National Kidney Month!

ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...

Urology of Virginia, a globally recognized leader in urologic care, is reinventing patient education and clinic efficiency ...

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.

Jefferson Regional Hospital’s Urology Associates will be participating in what’s being called a “March Madness Wellness Event ...